The Australians think they have found a way to deal with cellulite, and it is in a cream. The company, or should I say companies behind this are the old Metabolic Pharmaceuticals (now Calzada Limited) and Phosphagenics. The product creating much hype is the BodyShaper Cellulite Contour Crème is said to use fat reducing active compounds.

After years of testing, Phosphagenics claims that the product is the real deal. In a press release they talked about a study where after 4 weeks, there was a 40% reduction in the appearance of cellulite and skins hydration and elasticity was also improved. The reason the two companies came together for this product are as follows:

Phosphagenics has something they like to call the TPM platform, which is a system that allows active ingredients to be delivered into the skin “effectively, safely, and non-invasively.” Calzada on the other hand had a novel lipolytic peptide (AOP 9604) that was able to reduce fat, by using the TPM system to administer AOP 9604, the brand claims that along with the help of caffeine and forskolin, fat cells can be broken down and released.

There is no word yet on  an exact launch day, the cost, or even the full list of ingredients but keep in mind that things don’t always work out as planned. One half of the BodyShaper Cellulite Contour Crème duo, Metabolic Pharmaceuticals (now Calzada) had once touted that very same AOP 9604 as a possible oral drug to help lose weight. It however didn’t work out and the drug failed. We’ll just have to wait to see if BodyShaper Cellulite Contour will face the same fate.